{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:55:41Z","timestamp":1790675741783,"version":"4.1.0"},"reference-count":117,"publisher":"Wiley","issue":"S2","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1111\/trf.70277","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:26:02Z","timestamp":1790411162000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enabling community\u2010based autologous adaptive immune cellular therapy manufactured at the point of care: A narrative review of global regulatory frameworks, affordability, and implementation strategy of a novel integrated facility and digital platform in the United States"],"prefix":"10.1111","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9237-5864","authenticated-orcid":false,"given":"R. Brent","family":"Dixon","sequence":"first","affiliation":[{"name":"BioCytics, Human Applications Lab  Huntersville North Carolina USA"},{"name":"Carolina BioOncology Institute Cancer Research Clinic  Huntersville North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Warin","sequence":"additional","affiliation":[{"name":"BioCytics, Human Applications Lab  Huntersville North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Montague","sequence":"additional","affiliation":[{"name":"BioCytics, Human Applications Lab  Huntersville North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Austin","sequence":"additional","affiliation":[{"name":"Carolina BioOncology Institute Cancer Research Clinic  Huntersville North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"John D.","family":"Powderly","sequence":"additional","affiliation":[{"name":"BioCytics, Human Applications Lab  Huntersville North Carolina USA"},{"name":"Carolina BioOncology Institute Cancer Research Clinic  Huntersville North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6711"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-011761"},{"key":"e_1_2_10_4_1","unstructured":"ThistlethwaiteF TheocharousP.Facilitating Adoptive Cell Therapy Clinical Trials. Applied Clinical Trials. 2020 [cited 2026 Feb 8]. Available from:https:\/\/www.appliedclinicaltrialsonline.com\/view\/facilitating-adoptive-cell-therapy-clinical-trials"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cobme.2021.100358"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100537"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cobme.2021.100340"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01981-8"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1167666"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.03.061"},{"key":"e_1_2_10_11_1","unstructured":"Cellular & Gene Therapy Guidelines. 2025 [cited 2026 Feb 8]. Available from:https:\/\/www.fda.gov\/vaccines-blood-biologics\/biologics-guidances\/cellular-gene-therapy-guidances"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-021-01407-9"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.04.1284"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.05.004"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11166-023-09406-2"},{"key":"e_1_2_10_16_1","unstructured":"WenzellR.1% Makes a Difference. [cited 2025 Sep 23]. Available from:https:\/\/www.linkedin.com\/in\/ronaldwenzell\/"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2011.1300"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/OP.20.00471"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03231-z"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/jlb\/lsac027"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.57264\/cer-2024-0118"},{"key":"e_1_2_10_22_1","unstructured":"LiuA.Gilead's Kite Exits China Cell Therapy Joint Venture with Fosun Pharma \u2013 International Biopharmaceut. FiercePharma. 2024 [cited 2025 Sep 11]. Available from:https:\/\/www.fiercepharma.com\/pharma\/gileads-kite-exits-china-cell-therapy-jv-fosun-pharma"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/go-24-00581"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2025.200977"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2024.200889"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2025.200980"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2024.25.5.1725"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.34172\/ijhpm.8543"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01866-5"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/17460751.2024.2427505"},{"key":"e_1_2_10_31_1","unstructured":"Charles River Associated.Unlocking Access to Future ATMPs in the UK. Comparing International Approaches. 2024 [cited 2026 Feb 8]. Available from:https:\/\/www.abpi.org.uk\/media\/gtoa2ygp\/abpi_unlocking_atmps_uk_report.pdf"},{"key":"e_1_2_10_32_1","unstructured":"JosephA.In the U.S. Scientists See Barriers to the Development of CAR\u2010T Cell Therapies. In Spain a Hospital Brews its Own. STAT News. 2023 [cited 2025 Sep 10]. Available from:https:\/\/www.statnews.com\/2023\/12\/19\/car\u2010t\u2010therapy\u2010spain\u2010hospital\/"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.02.057"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2014.03.005"},{"key":"e_1_2_10_35_1","unstructured":"Miltenyi Biotec Cell Manufacturing Products. [cited 2025 Sep 23]. Available from:https:\/\/www.miltenyibiotec.com\/US\u2010en\/products\/cell\u2010manufacturing\u2010platform\/clinimacs\u2010prodigy\u2010platform.html?query=:relevance:allCategoriesOR:10000266"},{"key":"e_1_2_10_36_1","unstructured":"Terumo Products. [cited 2025 Sep 24]. Available from:https:\/\/www.terumobct.com\/en\/gl\/products\u2010services\/additional\u2010products\u2010and\u2010services\/additional\u2010products\/welders\u2010and\u2010sealers\/tscd\u2010ii\u2010sterile\u2010tubing\u2010welder.html"},{"key":"e_1_2_10_37_1","unstructured":"bioMerieux Sterility Testing. [cited 2025 Sep 24]. Available from:https:\/\/www.biomerieux.com\/corp\/en\/our\u2010offer\/industry\u2010products\/bact\u2010alert\u20103d\u2010cgt.html"},{"key":"e_1_2_10_38_1","unstructured":"Charles River Endotoxin Testing. [cited 2026 Feb 8]. Available from:https:\/\/www.criver.com\/products\u2010services\/qc\u2010microbial\u2010solutions\/endotoxin\u2010testing\/endotoxin\u2010testing\u2010systems\/endosafe\u2010nexgen\u2010pts?region=3611"},{"key":"e_1_2_10_39_1","unstructured":"Lonza Mycoplasma Detection. [cited 2025 Sep 23]. Available from:https:\/\/bioscience.lonza.com\/lonza_bs\/US\/en\/Cell\u2010analysis\/p\/000000000000186472\/MycoAlert\u2010Mycoplasma\u2010Detection\u2010Kit\u2010%28100\u2010Tests%29"},{"key":"e_1_2_10_40_1","unstructured":"G\u2010Con Bio Prefabricated Pod Cleanrooms. [cited 2026 Feb 8]. Available from:https:\/\/www.gconbio.com\/pod-cleanroom\/"},{"key":"e_1_2_10_41_1","unstructured":"bioBUBBLE Cleanrooms. [cited 2026 Feb 8]. Available from:https:\/\/biobubble.com\/"},{"key":"e_1_2_10_42_1","unstructured":"FDA.Title 21 Part 1271. Code of Federal Regulations. [cited 2025 Sep 23]. Available from:https:\/\/www.ecfr.gov\/current\/title-21\/chapter-I\/subchapter-L\/part-1271"},{"key":"e_1_2_10_43_1","unstructured":"FDA.Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue\u2010Based Products. 1998 [cited 2026 Feb 8]. Available from:https:\/\/www.govinfo.gov\/content\/pkg\/FR-1998-05-14\/pdf\/98-12751.pdf"},{"key":"e_1_2_10_44_1","unstructured":"Immune Cell Therapy References Since 1998. Available from:https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=immune+cell+therapy&filter=dates.1998\u20102026%2F6%2F1(cited June 1 2026)"},{"key":"e_1_2_10_45_1","volume-title":"CDER Distributed Manufacturing and Point\u2010of\u2010Care Manufacturing of Drugs","author":"FDA, CDER","year":"2022"},{"key":"e_1_2_10_46_1","unstructured":"FDA Reiterates guidance plans on distributed and point\u2010of\u2010care manufacturing RAPS Regulatory News Release 2023[cited 2026 June 1]. Available from:https:\/\/www.raps.org\/resource\/fda\u2010reiterates\u2010guidance\u2010plans\u2010on\u2010distributed\u2010and\u2010p.html"},{"key":"e_1_2_10_47_1","unstructured":"CBER.Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products. Guidance document. 2023 [cited 2026 Feb 8]. Available from:https:\/\/www.fda.gov\/media\/170198\/download"},{"key":"e_1_2_10_48_1","unstructured":"FDA.FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation. FDA News Release. 2026 [cited 2026 Feb 8]. Available from:https:\/\/www.fda.gov\/news\u2010events\/press\u2010announcements\/fda\u2010increases\u2010flexibility\u2010requirements\u2010cell\u2010and\u2010gene\u2010therapies\u2010advance\u2010innovation"},{"key":"e_1_2_10_49_1","unstructured":"UK Medicines and Healthcare Products Regulatory Agency.Human Medicines Modular Manufacture and Point of Care Regulations 2025: Overview. [cited 2026 Feb 8]. Available from:https:\/\/www.gov.uk\/government\/publications\/human\u2010medicines\u2010modular\u2010manufacture\u2010and\u2010point\u2010of\u2010care\u2010regulations\u20102025\u2010overview\/human\u2010medicines\u2010modular\u2010manufacture\u2010and\u2010point\u2010of\u2010care\u2010regulations\u20102025\u2010overview"},{"key":"e_1_2_10_50_1","unstructured":"Medicines & Healthcare Products Regulatory Agency.A Broadened Spectrum of Manufacturing and Supply Options. 2025 [cited 2026 Feb 8]. Available from:https:\/\/assets.publishing.service.gov.uk\/media\/6846f9434d039a010411f118\/Spectrum_of_manufacturing.pdf"},{"key":"e_1_2_10_51_1","unstructured":"Euro GCT.ATMPs Specific \u201cHospital Exemption\u201d Pathway. 2025 [cited September 29 2025]. Available from:https:\/\/www.eurogct.org\/research\u2010pathways\/therapy\u2010classification\/atmps\u2010applicable\u2010regulatory\u2010pathways\/atmps\u2010specific"},{"key":"e_1_2_10_52_1","unstructured":"Act on the Safety of and Support for Advanced Regenerative Medicine and Advanced Biopharmaceuticals. Press Release from the South Korean Ministry of Food and Drug Safety. 2020 [cited 2025 Sep 23]. Available from:https:\/\/www.mfds.go.kr\/eng\/brd\/m_61\/view.do?seq=10"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2016.04.001"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.251"},{"key":"e_1_2_10_55_1","unstructured":"Regulatory Overview of Cell Tissue or Gene Therapy Product: Understand the Scope of Regulations of Cell Tissue or Gene Therapy Products in Singapore. 2025 [cited 2026 Feb 8]. Available from:https:\/\/www.hsa.gov.sg\/ctgtp\/regulatory-overview"},{"key":"e_1_2_10_56_1","unstructured":"Medical Device Reforms: Point\u2010of\u2010Care Manufacturing of Medical Devices. 2025 [cited 2026 Feb 8]. Available from:https:\/\/www.tga.gov.au\/products\/regulations\u2010all\u2010products\/tga\u2010reforms\/medical\u2010devices\u2010reforms\/medical\u2010device\u2010reforms\u2010point\u2010care\u2010manufacturing\u2010medical\u2010devices"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01463-y"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01616-8"},{"key":"e_1_2_10_59_1","unstructured":"Outline of Health Care Insurance System. 2010 [cited 2026 Feb 8]. Available from:https:\/\/www.mhlw.go.jp\/english\/wp\/wp-hw3\/dl\/2-001.pdf"},{"key":"e_1_2_10_60_1","unstructured":"Zolgensma Proposed to Cost 167 Million Yen in Japan. 2020 [cited 2026 Feb 8]. Available from:https:\/\/www.eversana.com\/2020\/05\/13\/japan-zolgensma-cost\/"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.2217\/rme-2022-0064"},{"key":"e_1_2_10_62_1","volume-title":"Cancer statistics","author":"National Cancer Institute","year":"2025"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0133"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2023.09.040"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-SITC2024.0429"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.18609\/cgti.2017.018"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.2196\/55779"},{"key":"e_1_2_10_68_1","unstructured":"PowderlyJ.Embedding Cancer Research Trials into openEHR for Electronic Data Capture to Develop Personalized Medicines Manufactured at the Point of Care. 2025 [cited 2026 Feb 8]. Available from:https:\/\/www.youtube.com\/watch?v=HNxiL8E-rxw"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.18609\/ioi.2021.011"},{"key":"e_1_2_10_70_1","unstructured":"US FDA Administration.Master Files for CBER Regulated Products; 2026 [cited 2026 May 28 2026]. Available from:https:\/\/www.fda.gov\/vaccines\u2010blood\u2010biologics\/development\u2010approval\u2010process\u2010cber\/master\u2010files\u2010cber\u2010regulated\u2010products"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-023-01380-x"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0210-z"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2021.10.001"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0488-6"},{"key":"e_1_2_10_75_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003763"},{"key":"e_1_2_10_76_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060"},{"key":"e_1_2_10_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.12.011"},{"key":"e_1_2_10_78_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053402"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3241"},{"key":"e_1_2_10_80_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxad051"},{"key":"e_1_2_10_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23319-1"},{"key":"e_1_2_10_82_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092607"},{"key":"e_1_2_10_83_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9060668"},{"key":"e_1_2_10_84_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.7.1149"},{"key":"e_1_2_10_85_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81622"},{"key":"e_1_2_10_86_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaj1853"},{"key":"e_1_2_10_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4237"},{"key":"e_1_2_10_88_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230892"},{"key":"e_1_2_10_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-024-00698-3"},{"key":"e_1_2_10_90_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2012.00069"},{"key":"e_1_2_10_91_1","doi-asserted-by":"publisher","DOI":"10.1039\/c9lc01122f"},{"key":"e_1_2_10_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20560"},{"key":"e_1_2_10_93_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2006388117"},{"key":"e_1_2_10_94_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers2021236"},{"key":"e_1_2_10_95_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1808"},{"key":"e_1_2_10_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.07.012"},{"key":"e_1_2_10_97_1","unstructured":"A Biospecimen Collection Study of Leukapheresis\u2010Derived Circulating Tumor Cells Immune Cells and Progenitor Cells. ClinicalTrials.gov [cited 2026 Feb 8]. Available from:https:\/\/clinicaltrials.gov\/study\/NCT00571389"},{"key":"e_1_2_10_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2013.08.026"},{"key":"e_1_2_10_99_1","unstructured":"A Biospecimen Collection Study of Leukapheresis\u2010Derived Circulating Tumor Cells Immune Cells and Progenitor Cells. [cited 2026 Feb 8]. Available from:https:\/\/clinicaltrials.gov\/study\/NCT00571389"},{"key":"e_1_2_10_100_1","unstructured":"BioCytics.BioCytics Successfully Completes a Key Regulatory Milestone with Recent FDA INTERACT Meeting. PR Newswire Press Release. AP Newswire. 2025 [cited 2026 Feb 8]. Available from:https:\/\/www.prnewswire.com\/news-releases\/biocytics-successfully-completes-a-key-regulatory-milestone-with-recent-fda-interact-meeting-302619172.html"},{"key":"e_1_2_10_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.03.023"},{"key":"e_1_2_10_102_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01984-2"},{"key":"e_1_2_10_103_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.872531"},{"key":"e_1_2_10_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-025-01523-w"},{"key":"e_1_2_10_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1656"},{"key":"e_1_2_10_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03476-6"},{"key":"e_1_2_10_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1802"},{"key":"e_1_2_10_108_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030805"},{"key":"e_1_2_10_109_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030406"},{"key":"e_1_2_10_110_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1723995"},{"key":"e_1_2_10_111_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfimm\/iqad006"},{"key":"e_1_2_10_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2020.01.013"},{"key":"e_1_2_10_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2007.07.012"},{"key":"e_1_2_10_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19094-0"},{"key":"e_1_2_10_115_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-419283"},{"key":"e_1_2_10_116_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3909"},{"key":"e_1_2_10_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05593-1"},{"key":"e_1_2_10_118_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010251"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70277","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/trf.70277","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:59:53Z","timestamp":1790672393000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.70277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":117,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1111\/trf.70277"],"URL":"https:\/\/doi.org\/10.1111\/trf.70277","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2025-09-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}